These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 36374122)
1. A cross-sectional study on substandard and falsified medicines (fake or counterfeit drugs) in UK pharmacies during the COVID-19 pandemic. Barrett R Expert Opin Drug Saf; 2023; 22(12):1289-1299. PubMed ID: 36374122 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of community pharmacists' readiness to implement the Falsified Medicines Directive (Directive 2011/62/EC): an English cross-sectional survey with geospatial analysis. Barrett R BMJ Open; 2020 Jan; 10(1):e033405. PubMed ID: 31924640 [TBL] [Abstract][Full Text] [Related]
3. Community pharmacists' knowledge of substandard and falsified medicines in clinical practice: a cross-sectional survey in Saudi Arabia. Bashayr Ali A; Barrett R Int J Pharm Pract; 2023 Apr; 31(2):176-182. PubMed ID: 36748987 [TBL] [Abstract][Full Text] [Related]
4. A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country. Khurelbat D; Dorj G; Sunderland B; Sanjjav T; Bayarsaikhan E; Damdinjav D; Dorj G; Jigjidsuren A; Lkhagvasuren O; Erdenetsetseg B BMC Public Health; 2020 May; 20(1):743. PubMed ID: 32434489 [TBL] [Abstract][Full Text] [Related]
5. Fighting trafficking of falsified and substandard medicinal products in Russia. Fayzrakhmanov NF Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702 [TBL] [Abstract][Full Text] [Related]
6. Falsified Drugs in the Opinion of Patients Diagnosed with Cardiovascular Diseases-Nationwide and Cross-Sectional Study on the Example of EU-Member Country. Świeczkowski D; Zdanowski S; Merks P; Jaguszewski M Int J Environ Res Public Health; 2021 Apr; 18(7):. PubMed ID: 33917444 [TBL] [Abstract][Full Text] [Related]
7. Point-of-Care Anti-Counterfeit Medicines Technologies: Awareness and Utilization among Medical Practitioners in Eastern Nigeria. Iloh GU; Akodu BA; Emeka EA; Obi IV West Afr J Med; 2021 Nov; Vol. 38(11):1029-1035. PubMed ID: 34918894 [TBL] [Abstract][Full Text] [Related]
8. Pharmacists' views on the impact of the Falsified Medicines Directive on community pharmacies: A cross-sectional survey. Dalton K; Connery C; Murphy KD; O'Neill D Explor Res Clin Soc Pharm; 2022 Mar; 5():100127. PubMed ID: 35478525 [TBL] [Abstract][Full Text] [Related]
9. The Epidemic of Substandard and Falsified Medications in Iraq: Evaluating the Effectiveness of National Pharmacovigilance Alerts to Community Pharmacies. Al-Jumaili AA; Younus MM; Saleh MZ Pharmaceut Med; 2021 May; 35(3):169-186. PubMed ID: 33864206 [TBL] [Abstract][Full Text] [Related]
10. Survey of workflow and cost implications of decommissioning regarding the Falsified Medicines Directive in Hungarian hospital pharmacies. Vajda P; Richter K; Bodrogi Z; Vida RG; Botz L; Kovács S; Zemplényi A; Bella R; Fittler A BMJ Open; 2021 Nov; 11(11):e047193. PubMed ID: 34815273 [TBL] [Abstract][Full Text] [Related]
11. The European Falsified Medicines Directive in Poland: background, implementation and potential recommendations for pharmacists. Merks P; Swieczkowski D; Byliniak M; Drozd M; Krupa K; Jaguszewski M; Brindley DA; Naughton BD Eur J Hosp Pharm; 2018 Jan; 25(1):10-15. PubMed ID: 29445453 [TBL] [Abstract][Full Text] [Related]
12. The role of pharmacists in eliminating counterfeit medicines in Nigeria. Adigwe OP Front Public Health; 2023; 11():1170929. PubMed ID: 37674683 [TBL] [Abstract][Full Text] [Related]
13. Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis. Ozawa S; Evans DR; Bessias S; Haynie DG; Yemeke TT; Laing SK; Herrington JE JAMA Netw Open; 2018 Aug; 1(4):e181662. PubMed ID: 30646106 [TBL] [Abstract][Full Text] [Related]
14. Trends in counterfeit drugs and pharmaceuticals before and during COVID-19 pandemic. Ziavrou KS; Noguera S; Boumba VA Forensic Sci Int; 2022 Sep; 338():111382. PubMed ID: 35882074 [TBL] [Abstract][Full Text] [Related]
15. Legal aspects of counteracting the trafficking of falsified medicines in the european union. Pashkov V; Soloviov A; Olefir A Wiad Lek; 2017; 70(4):843-849. PubMed ID: 29064815 [TBL] [Abstract][Full Text] [Related]
16. Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance. Pisani E; Hasnida A; Rahmi M; Kok MO; Harsono S; Anggriani Y JMIR Public Health Surveill; 2021 Aug; 7(8):e29309. PubMed ID: 34181563 [TBL] [Abstract][Full Text] [Related]
17. A narrative review of illegal online pharmacies and contemporary issues with restricting FDA-approved medication access. Jillani Z; Reinhard L; Hertig J J Med Access; 2023; 7():27550834231220512. PubMed ID: 38149839 [TBL] [Abstract][Full Text] [Related]
18. Public health interventions to protect against falsified medicines: a systematic review of international, national and local policies. Hamilton WL; Doyle C; Halliwell-Ewen M; Lambert G Health Policy Plan; 2016 Dec; 31(10):1448-1466. PubMed ID: 27311827 [TBL] [Abstract][Full Text] [Related]
19. A review of existing and emerging digital technologies to combat the global trade in fake medicines. Mackey TK; Nayyar G Expert Opin Drug Saf; 2017 May; 16(5):587-602. PubMed ID: 28349715 [TBL] [Abstract][Full Text] [Related]
20. Combatting Substandard and Falsified Medicines: Public Awareness and Identification of Counterfeit Medications. El-Dahiyat F; Fahelelbom KMS; Jairoun AA; Al-Hemyari SS Front Public Health; 2021; 9():754279. PubMed ID: 34765583 [No Abstract] [Full Text] [Related] [Next] [New Search]